In addition to helping people with diabetes control symptoms, drugmakers say GLP-1 medicines improve cardiometabolic markers in both diabetic and non-diabetic patients with obesity
As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less processed foods and soda, researchers say food and beverage companies are adjusting strategies
Thus, phagocytes, whose age-related changes were studied by us a long time ago(46), were thought to play a less critical role in the immune dysfunction that occurs throughout aging
And hey, those things can pop up way earlier than expected, thanks to a bunch of reasons some inside our bodies, others from the world outside
Research points to clear, practical strategies that can protect lean mass during GLP-1 therapy
But real-world outcomes depend on medication adherence, dose titration monitoring, nutrition guidance, side-effect management, and ongoing follow-up